Streetbeat News

Stock Prices

XNET

Xunlei expects its Q4 revenue to be in the range of $70M-$75M. The midpoint of this range indicates a quarter-over-quarter decrease of about 8.6%.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:15 am

SKIN

Piper Sandler analyst Korinne Wolfmeyer downgraded Beauty Health (NASDAQ:SKIN) from Overweight to Underweight and significantly reduced the price target from $12 to $2, indicating a bearish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:15 am

SKIN

Canaccord Genuity analyst Susan Anderson downgraded Beauty Health (NASDAQ:SKIN) from Buy to Hold and reduced the price target from $10 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:12 am

BZ

KANZHUN Limited, which operates the online recruitment platform BOSS Zhipin, forecasts its Q4 revenues to be between RMB1.51 billion and RMB1.55 billion, indicating a year-over-year growth of 39.6% to 43.3%.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:12 am

HUYA

HUYA Inc. (NYSE:HUYA) reported Q3 earnings with an EPS of $0.06, surpassing the estimated EPS of $-0.03 by 300%. However, revenue declined to $108.52 million compared to the same period last year. Despite beating EPS estimates last quarter, HUYA's share price fell by 3.42% the following day. The company's past earnings performance shows variability in meeting EPS estimates but a consistent decline in revenue over the last four quarters.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 11:10 am

RBOT

Canaccord Genuity analyst Caitlin Cronin downgraded Vicarious Surgical (RBOT) from Buy to Hold and significantly reduced the price target from $9 to $0.4, indicating a bearish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:10 am

CSIQ

Canadian Solar (NASDAQ:CSIQ) reported Q3 earnings with an EPS of $0.32, missing the estimate of $0.82 by 60.98%. Revenue also declined from the same period last year by $85.72 million. In contrast, last quarter, CSIQ beat EPS estimates which resulted in a slight share price increase the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 11:10 am

OCSL

Oaktree Specialty Lending (NASDAQ:OCSL) reported Q4 earnings with an EPS of $0.62, slightly missing the estimate of $0.63 by 1.59%. Revenue increased by $31.76 million compared to the same period last year. Despite missing EPS estimates last quarter, the share price increased by 0.6% the following day. The company's past earnings performance shows a consistent pattern of meeting or closely approaching EPS estimates while growing revenue over the last four quarters.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 11:10 am

BZ

Kanzhun reported Q3 adjusted earnings of $0.22 per share, an 83.33% increase from $0.12 per share in the same period last year. Sales rose 32.91% to $220.21M from $165.68M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:09 am

RMTI

Rockwell Medical (NASDAQ:RMTI) reported Q3 earnings with an EPS of $-0.07, beating estimates by 30% against an expected $-0.1. Revenue increased by $5.08 million compared to the same period last year. Despite beating this quarter, the company's share price dropped 3.16% the day after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 11:05 am